Cardiology, ophthalmology and oncology/urology have some of the highest earnings before interest, taxes, depreciation and amortisation multiples in today’s market, according to a Nov. 18 report from Focus Investment Bankers.
Here’s a breakdown of average EBITDA multiples, by physician specialty:
- Primary care: Platform deals typically price at eight to 12 times EBITDA (add-ons three to six times), with scaled value-based platforms reaching the low teens.
- Cardiology: Platforms often trade at 12 to 15 times (add-ons eight to 12 times) amid a scarcity of large independent groups.
- Orthopedics/sports medicine: Platforms generally land at nine to 13 times (add-ons six to nine times), supported by ASC and imaging ancillaries.
- Gastroenterology: Platform multiples are commonly 10 to 14 times (add-ons seven to nine times), with endoscopy and ASC ownership lifting valuations.
- Ophthalmology: Platforms range at 12 to 20 times (add-ons seven to 11 times), with retina care supported by recent public-company activity and broader ranges where ASC/clinic density is higher.
- OB-GYN/women’s health: Platforms typically trade 10 to 14 times (add-ons five to eight times). The sector remains active, though the market is showing some multiple compression.
- Plastic surgery/aesthetics: Platforms are often eight to 12 times (add-ons four to eight times); smaller single-site aesthetics can be low- to mid-single digits, while scaled groups can reach high-single to low-double digits.
- Oncology/urology: Platforms commonly price at 14 to 19 times (add-ons eight to 12 times), with oncology precedent transactions reaching approximately 19 times in certain structures and urology showing steady add-on cadence.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
